- Home
- EZGO vs ONCO Comparison
EZGO vs ONCO Comparison
Compare EZGO & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- ONCO
- Stock Information
- Founded
- EZGO 2014
- ONCO 2018
- Country
- EZGO China
- ONCO United States
- Employees
- EZGO N/A
- ONCO N/A
- Industry
- EZGO Motor Vehicles
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- ONCO Health Care
- Exchange
- EZGO Nasdaq
- ONCO Nasdaq
- Market Cap
- EZGO 2.0M
- ONCO 1.8M
- IPO Year
- EZGO 2021
- ONCO 2022
- Fundamental
- Price
- EZGO $0.31
- ONCO $4.76
- Analyst Decision
- EZGO
- ONCO
- Analyst Count
- EZGO 0
- ONCO 0
- Target Price
- EZGO N/A
- ONCO N/A
- AVG Volume (30 Days)
- EZGO 112.1K
- ONCO 232.8K
- Earning Date
- EZGO 01-17-2025
- ONCO 06-12-2025
- Dividend Yield
- EZGO N/A
- ONCO N/A
- EPS Growth
- EZGO N/A
- ONCO N/A
- EPS
- EZGO N/A
- ONCO N/A
- Revenue
- EZGO $20,895,830.00
- ONCO $1,925,313.00
- Revenue This Year
- EZGO N/A
- ONCO N/A
- Revenue Next Year
- EZGO N/A
- ONCO N/A
- P/E Ratio
- EZGO N/A
- ONCO N/A
- Revenue Growth
- EZGO 18.98
- ONCO 153.70
- 52 Week Low
- EZGO $0.29
- ONCO $3.82
- 52 Week High
- EZGO $1.91
- ONCO $1,190.00
- Technical
- Relative Strength Index (RSI)
- EZGO 36.43
- ONCO 43.17
- Support Level
- EZGO $0.30
- ONCO $4.40
- Resistance Level
- EZGO $0.35
- ONCO $5.10
- Average True Range (ATR)
- EZGO 0.02
- ONCO 0.60
- MACD
- EZGO -0.00
- ONCO 0.07
- Stochastic Oscillator
- EZGO 11.30
- ONCO 27.72
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.